Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Withdrawal in Opioid-Induced Esophageal Dysfunction
NCT06522633Phase 3Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Nov 2020
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by Hospital Clínic de Barcelona. Primary endpoint: Improvement in Esophageal Motility at 7 days. Started Nov 2020; status: completed.
Beyond the preview
Go deeper on NCT06522633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06522633.